The collected sample may have a low concentration of the target molecules, making them difficult to be detected.NEXT
DIAGNOSTICS PERFORM THE
CRITICAL FUNCTION OF
IDENTIFYING THREATS TO
Are we suffering from diseases that have yet to manifest symptoms?
The potential beneﬁts of accurate diagnostics are immense , but target molecules that indicate the presence of disease often exist in quantities too low to be detected in collected samples.
PHASE Scientiﬁc has developed an
innovative solution to the problem of
low-concentration target molecule
Imagine a glass of water containing trace amounts of salt that cannot be tasted. Our proprietary technology PHASIFY™ concentrates and puriﬁes test samples, making target molecules easier to detect. Our glass of water is effectively distilled to a few drops, revealing the salty taste.
This technology shortens the concentration process from hours to minutes, facilitating its integration into testing devices from simple point-of-care tests to complex, lab-based instruments.
PHASIFY™ improves the performance
of point-of-care and lab-based
By improving sample quality,
our technology increases the sensitivity, performance
and affordability of point-of-care and
A TRANSFORMATION IN
DISEASE DETECTION AND TREATMENT
Enhanced diagnostic tools produce more accurate and
accessible health information.
These tools support prevention and earlier treatment,
improving outcomes and lowering healthcare costs.
Increased decision-making and
ownership over their health.
FOR HEALTHCARE PROVIDERS
Greater ability to diagnose and
New tools that facilitate timely
detection and treatment decisions
to control diseases.